Do you Know??? about Chlamydia

Overview

Genital chlamydia (pronounced kla-mid-ee-uh), a microorganism sexually transmitted sickness (STD) caused by the bacteriumChlamydia trachomatis, is that the most often reportable STD within the us nowadays.

It occurs most frequently among teenagers and young adults, according to the U.S. Centers for Disease Control and Prevention (CDC). In fact, among females, the highest rates of chlamydia occur in those aged 15 to 24. In 2011, over 1.4 million chlamydia infections were reported to CDC, but an estimated 2.8 million infections occur annually in the United States.

Initially, in females, the bacteria invade cells lining the endocervix (the opening to the uterus). As it spreads into the reproductive tract, it can eventually lead to infertility, ectopic pregnancy and chronic pelvic pain. It has been calculable that chlamydia causes no symptoms in up to seventy p.c to ninety five p.c of females and ninety p.c of males. It is sometimes called a “silent” disease. Because chlamydia is sometimes silent however will cause serious complications, such as infertility, routine annual screening of all sexually active young females 25 years and younger is recommended.

Chlamydia is very common, particularly in young females. In fact, office estimates that one in fifteen sexually active females aged fourteen to nineteen years has chlamydia.

When diagnosed, chlamydia is easily treated and cured. Left untreated, it can lead to significant medical problems for females, one of the most serious being pelvic inflammatory disease (PID). PID may be a generic term indicating varied inflammatory disorders of the higher reproductive organ tract, including endometritis and tubo-ovarian abscess. Acute PID can be difficult to diagnose. Its signs and symptoms vary widely, and many females have only subtle symptoms.

In addition to inflammatory disease, chlamydia will cause inflammation (inflamed rectum) and redness (inflammation of the attention lining). It also increases risk for HIV and other STDs, as well as cervical cancer.

Chlamydia and PID

The following factors may increase your risk for developing PID:

  • previous episodes of PID or STDs
  • multiple sex partners or a partner with multiple sex partners
  • being under age 25
  • douching

It’s a common misconception that the use of an intrauterine device (IUD) increases the risk of developing PID. The risk of developing PID is minimally increased during the first 20 days after insertion of the device, but after that time the risk returns to baseline. This risk can be reduced by testing for STDs before IUD insertion and treating appropriately. IUDs are an extremely safe and effective means of preventing pregnancy, with less than 1 percent unintended pregnancies per year.

Chlamydia infection is one in all the foremost common causes of inflammatory disease. It has been estimated that up to 10 percent to 20 percent of females with untreated chlamydia will develop PID. Some females with PID will become infertile. Other potential complications include chronic pelvic pain and life-threatening ectopic pregnancy, which is a leading cause of pregnancy-related deaths for American females in the first trimester.

Annual chlamydia screening for sexually active females beneath twenty five years previous is price effective as a result of it will stop serious generative complications, such as infertility, ectopic pregnancy and chronic pelvic pain.

Chlamydia and HIV

Research has shown that females infected with chlamydia square measure up to 5 times additional possible to amass HIV if exposed to the virus. The reason for the increased risk may be that chlamydia causes a spike in the number of white blood cells at the site of infection. Some of these system cells, while needed to fight the infection, also happen to be the main target for HIV.

Chlamydia and Cervical Cancer

Some studies have shown AN accumulated risk of cervical cancer in females WHO have had chlamydia. Although infections with cancer-causing strains of human papillomavirus (HPV) stay the prime reason behind cervical cancer, infection with certain subtypes of Chlamydia trachomatis may contribute to that risk.

In 1993, Congress set aside funds to begin a national STD-related infertility prevention program that has led to significant increases in chlamydia screening. In addition, all medical professional associations, such as the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics and the American Association of Family Physicians, recommend routine chlamydia screening annually for all females under 25. As a result, more public and private health care professionals have been screening young females. Because most young females still are not tested, health officials estimate that the actual number of infections is much higher than reported.

Reported female cases greatly exceed those for males. The reasons for this are unclear, but it may be that fewer males are screened routinely for chlamydia, often presenting for testing only when they have symptoms.

Fortunately, increased awareness of the seriousness of chlamydia has put pressure on health care professionals to offer regular screening to younger females. In the year 2000, chlamydia was added to the list of performance measures for the Healthcare Effectiveness Data and Information Set. This tool rates how well managed care organizations perform on a variety of clinical measures, including prevention efforts for breast cancer, controlling blood cholesterol levels and childhood immunizations. While this does not make chlamydia screening mandatory, managed care organizations are now evaluated on how well they meet the established guideline of offering yearly chlamydia testing to sexually active females between ages 15 and 25 years.

In addition, the Patient Protection and Affordable Care Act (ACA) requires insurance companies to cover the cost of chlamydia screening, as well as some other STD testing and prevention counseling.

Chlamydia in Pregnancy

A small share of pregnant females square measure infected with chlamydia. In pregnant females, untreated chlamydia has been associated with pre-term delivery Transmission to the newborn results from exposure to the mother’s infected cervix during birth. All females ought to be screened for chlamydia as a part of routine antenatal care. Infants with chlamydia may be born prematurely. They also may experience eye inflammation (conjunctivitis) and breathing problems. Chlamydia infection can also involve the cavity, genital tract and rectum. Infection typically will cause respiratory illness throughout AN infant’s initial months. Recommended treatment for baby chlamydia is Pediamycin base divided in four daily doses for fourteen days.

Diagnosis

Part of what makes chlamydia therefore troublesome to diagnose is that it’s for the most part asymptomatic; in alternative words, somebody may be infected for months or longer and ne’er recognize they have the infection. When symptoms do occur, they often are mild—a burning sensation when urinating and/or a discharge from the vagina or penis are typical symptoms. Females may additionally expertise pain within the girdle space or discomfort or hemorrhage throughout sex. Health care professionals might not address these symptoms, probably resulting in the chlamydia infection remaining untreated. If left untreated in females, it may result in PID.

PID will occur at intervals days or many months once being infected with chlamydia. At this time, symptoms still might go unperceived in some females, yet they do have an active PID infection. Other females, however, might expertise hemorrhage between expelling periods, lower back pain, pain during sexual penetration, increased vaginal discharge and severe pelvic pain. Treatment for these females may require hospitalization and intravenous antibiotics.

Testing is the only way to know whether you have chlamydia. CDC recommends annual screening for all sexually active females 25 years of age and younger and for older females with risk factors (such as, those who have a new sex partner and those with multiple sex partners). All females with signs of infection of the cervix and all pregnant females should be tested.

The most sensitive chlamydia tests, called nucleic acid amplification tests (NAATs), can be performed on a urine specimen or a self-collected vaginal swab. An invasive genital exam is not always required. However, a chlamydia take a look at also can be performed on a swab of the cervix collected as a part of a girdle examination or a duct swab collected on males. It may take several days before you can get a test result.

Treatment

If you take a look at positive for chlamydia, your infection can be cured with antibiotics. Depending on several factors, your health care professional may prescribe azithromycin, in which case you will take only a single dose of a few pills, or you may be prescribed antibiotic drug, which requires one pill twice a day for seven days.

If you’re pregnant and infected with chlamydia, you still can be treated without harming the fetus. However, doxycycline is not recommended during pregnancy. The recommended regimen for pregnant females is azithromycin pills taken in a single dose. As with any antibiotic treatment, it is important that you take all your pills.

Too often, females become reinfected because their partner has not been treated. Studies have shown that females UN agency ar reinfected with chlamydia have a far larger risk of developing PID. Therefore, it is important that you abstain from sexual contact until a week after your partner has been tested and completed treatment, meaning seven days after a single-dose azithromycin regimen or after completion of a seven-day doxycycline regimen. In addition, you should return to your doctor for a repeat test three to six months after you are treated to be sure that you have not been infected again.

In general, treatment is usually recommended for any partner or partners you had sexual contact with up to sixty days before having symptoms or a identification of chlamydia. Some clinics and doctors’ offices offer what is called expedited partner therapy (EPT). Patients are given a prescription or the medication that treats chlamydia to give to their partner(s) without the clinician assessing the partner. There are legal and ethical debates about this approach, and it does have some limitations (including loss of screening and counseling opportunities and the potential for adverse reactions to antibiotics), but in some cases it may be the most effective way to stop the spread of chlamydia, because many infected male partners have no symptoms and are reluctant to seek treatment.

EPT is legal in several U.S. states and cities. For more information on its legal status.

In some cases, people infected with chlamydia are also infected with gonorrhea. Therefore, testing for gonorrhea is often done at the same time as testing for chlamydia. If an individual tests positive for each infections, additional treatment is necessary.

PID treatment begins with associate degree antibiotic program that gives broad coverage against many microorganism. Treatment should begin as soon as a diagnosis is made, because immediate therapy has been shown to reduce the risk of long-term consequences of PID. Antibiotics may be given by mouth or injection. There are several treatment options recommended by CDC. Regardless of which type of therapy is chosen, hospitalization is no longer recommended, except in certain circumstances including:

  • surgery is needed
  • an oral outpatient regimen cannot be tolerated
  • a patient is pregnant
  • a patient does not respond clinically to oral antimicrobial therapy
  • a patient has severe illness, including high fever and vomiting
  • a patient has tubo-ovarian abscess or a weakened immune system

While medication can stop PID, some females may need surgery to remove scar tissue and blockages caused by long-term infection.

Prevention

Protecting yourself from chlamydia needs identical care and a focus required to forestall alternative sexually transmitted diseases (STDs). If you have already been infected, you should be vigilant in preventing reinfection, which can increase your risk of infertility.

Abstinence is one positive manner to not become infected, as the spread of chlamydia is almost always limited to sexual contact. If you have sex, make sure you use a latex condom from the beginning to the end of sexual contact every time you have sex. Latex condoms offer the best available means of reducing your risk of contracting an STD when they are used consistently and correctly.

Also grasp that your risk for chlamydia infection will increase with the a lot of sexual partners you’ve got. If you are sexually active and 25 years of age or younger, or if you are older but have any risk factors for chlamydia, you should ask your provider to test you at least once a year. Risk factors embrace being young and sexually active, having multiple sex partners, and having previous infection with other STDs.

Women who have sex with women—either exclusively or in addition to male partners—are also at risk for chlamydia. Women United Nations agency jazz completely with girls could also be at a ablated risk, but they should still take precautions. Lesbians and bisexual females need to consider the following precautions to protect themselves from contracting these diseases.

  • Ask about the sexual history of current and future sex partners.
  • Reduce your number of sex partners.
  • If you have sex with a male partner, always use a condom from start to finish during any type of sex (vaginal, anal and oral). Use latex condoms rather than natural membrane condoms. If used consistently and correctly, latex condoms offer greater protection against STD agents, including HIV.
  • Use only water-based lubricants. Oil-based lubricants like mineral jelly and vegetable shortening will destroy condoms. If you choose to use a contraceptive together with a birth control device, it’s preferred to use contraceptive within the canal in step with manufacturer’s directions. As of December 2007, the U.S. Food and Drug Administration (FDA) mandated a new warning for the labels of over-the-counter vaginal contraceptives that contain the spermicide nonoxynol-9. The warning states that vaginal contraceptives containing nonoxynol-9 do not protect against infection from HIV (human immunodeficiency virus, the AIDS virus) or other STDs. The FDA’s warning conjointly advises customers that the utilization of channel contraceptives containing nonoxynol-9 will increase channel irritation, which may increase the possibility of transmitting the AIDS virus and other STDs from infected partners.
  • Get tested for chlamydia once a year if you are 25 years or younger or have other risk factors.

Facts to Know

1. In 2011, the rate of reported chlamydia infections in females was more than two and a half times the rate among males, likely the result of a larger number of females being screened for the infection.

2. Studies have shown that routine chlamydia screening and treatment can significantly reduce the incidence of lower genital tract chlamydia, as well as pelvic inflammatory disease, ectopic pregnancy, chronic pelvic pain and infertility.

3. Up to 95 percent of infected females and 90 percent of infected males have no symptoms of chlamydia, and the majority of cases go undiagnosed.

4. Rates of positive chlamydia tests in females tested in family planning clinics rose 3.8 percent between 2009 and 2010. Rather than evidence of an escalating epidemic, this trend mostly reflects increased screening of asymptomatic females and improved reporting.

5. Research has shown that females infected with chlamydia are up to five times more at risk of acquiring HIV than females not infected.

6. It is estimated that up to 30 percent of females not treated for chlamydia will develop pelvic inflammatory disease (PID). PID increases a woman’s chances of infertility, chronic pelvic pain or life-threatening ectopic pregnancy.

7. Rates of chlamydia rose in all regions of the country between 2002 and 2011. In 2011, rates of the disease were highest in the South (505.3 per 100,000), followed by the Midwest (445.7), the West (424.9) and the Northeast (415.8).

8. The rate of chlamydia among African-American females was more than seven times higher than the rate among Caucasians in 2011, according to the Centers for Disease Control and Prevention.

Key Q&A

1. What is chlamydia?

Chlamydia infection is caused by a bacterium called Chlamydia trachomatis. The bacterium can be transmitted during sexual intercourse or by oral-genital contact with an infected person.

2. If so many people with chlamydia don’t have symptoms, why is it necessary to get treated?

Even though infection often is asymptomatic, it can still cause serious consequences for females, and for pregnant females and their infants. Also, the only way to stop the epidemic is by treating everyone infected, whether they have symptoms or not.

3. How will chlamydia infection affect my chances of getting pregnant?

It depends on several factors, such as how long you have been infected and whether the infection has migrated into your upper genital tract. Pelvic inflammatory disease, which is often caused by chlamydia infection, can lead to infertility.

4. Does having chlamydia put me at greater risk for other sexually transmitted diseases (STDs)?

Yes. Chlamydia infection increases your risk of HIV by producing more of the type of white blood cells to which HIV attaches itself. Individuals are also frequently infected with more than one STD at a time. These STDs are often transmitted at the same time, so if you have acquired chlamydia, you may also be at risk for having other STDs.

5. What are the side effects of chlamydia treatment?

Chlamydia can be cured with antibiotics without causing significant side effects. The most common side effects are upset stomach, nausea, vomiting and diarrhea.

6. How is pelvic inflammatory disease treated?

In most cases, the first line of treatment is oral antibiotics. More serious cases or special circumstances may require intravenous drugs and hospitalization.

7. Why are more females diagnosed with chlamydia than males?

One reason is that unless they have symptoms, most males are never tested for chlamydia. Females, on the other hand, although they are more likely not to have symptoms of the disease, do have annual exams and therefore more opportunities to be screened for infection.

8. Can a pregnant females pass chlamydia to her infant?

Yes. The infection can be transmitted during birth and can cause eye and lung infection in a newborn. Fortunately, a pregnant female can take medication that will cure chlamydia without harming her or her child.